Antiviral Antibody Immune Responses in the Context of Vaccination and Infection
A special issue of Antibodies (ISSN 2073-4468). This special issue belongs to the section "Humoral Immunity".
Deadline for manuscript submissions: 15 December 2025 | Viewed by 18
Special Issue Editors
2. Indian Institute of Technology Palakkad, Kerala 678623, India
Interests: immunology; immune homeostasis; immunotherapy; host-pathogen interaction
Special Issues, Collections and Topics in MDPI journals
Interests: zika virus; cytomegalovirus; toxoplasma gondii; virus peptides
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Antiviral antibody responses play a critical role in the defense against viral infections. In the context of emerging viral diseases, understanding the dynamics of these responses has become increasingly critical. Neutralizing antibodies, which block viral entry into host cells, remain a primary goal for vaccines, as they provide robust and often long-lasting protection. However, challenges persist, including the rapid mutation rates of viruses like influenza and SARS-CoV-2, which can undermine vaccine efficacy.
The advent of new-generation vaccines, including mRNA-based platforms, has revolutionized the landscape of antiviral immunity. These vaccines have demonstrated the capacity to elicit strong antibody responses while being rapidly adaptable to emerging viral variants. Furthermore, novel adjuvants are enhancing the quality and durability of antibody responses by fine-tuning the immune system’s activation and promoting the production of broadly neutralizing antibodies.
We invite submissions focusing on "Antiviral Antibody Immune Responses in the Context of Vaccination and Infection". We encourage contributions that explore the mechanisms of antibody generation in response to viral infections and vaccines, the role of neutralizing antibodies, the comparative analysis of responses induced by vaccination versus natural infection, physicochemical characterization of antibody responses, and molecular and cellular insights into B cell responses. Submissions highlighting the impact of new-generation vaccine platforms, such as mRNA and viral vector vaccines, are particularly welcome. Additionally, we invite research on novel adjuvants and their role in enhancing the quality, durability, and breadth of antiviral antibody responses. We will consider both original research articles and comprehensive reviews related to the subject area.
Prof. Dr. Jagadeesh Bayry
Dr. Guglielmo Lucchese
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibodies is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virus
- B lymphocytes
- antibodies
- viral vaccines
- functional assays
- physicochemical characterization
- BCR
- affinity maturation
- avidity
- affinity
- protection
- human
- veterinary
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
